These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1288734)

  • 1. Synergistic cytotoxicity of combinations of dimethyl sulfoxide and antineoplastic agents against P388 leukemia in CD-F1 mice.
    Pommier RF; Woltering EA; Milo G; Fletcher WS
    Anticancer Drugs; 1992 Dec; 3(6):635-9. PubMed ID: 1288734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of dimethyl sulfoxide and antineoplastic combinations against human tumors.
    Pommier RF; Woltering EA; Milo G; Fletcher WS
    Am J Surg; 1988 May; 155(5):672-6. PubMed ID: 3369622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic cytotoxicity between dimethyl sulfoxide and antineoplastic agents against ovarian cancer in vitro.
    Pommier RF; Woltering EA; Milo G; Fletcher WS
    Am J Obstet Gynecol; 1988 Oct; 159(4):848-52. PubMed ID: 3177534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs.
    Alberts DS; Dorr RT; Wunz TP; Remers WA; Einspahr J; Liu R; Salmon SE
    Anticancer Drugs; 1991 Feb; 2(1):69-77. PubMed ID: 1958855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study for modifying activity of solvents on antitumor activity of paclitaxel].
    Fujimoto S
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):665-70. PubMed ID: 7908793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia.
    Waud WR; Harrison SD; Gilbert KS; Laster WR; Griswold DP
    Cancer Chemother Pharmacol; 1991; 27(6):456-63. PubMed ID: 1849465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline.
    Coluccia M; Sava G; Loseto F; Nassi A; Boccarelli A; Giordano D; Alessio E; Mestroni G
    Eur J Cancer; 1993; 29A(13):1873-9. PubMed ID: 8260245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoclopramide and nitrendipine are unable to enhance cytotoxicity of mitoxantrone in sensitive and resistant murine leukemias in vivo.
    Potemski P; Polakowski P
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):249-53. PubMed ID: 9597095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
    Chandrasekaran B; Dimling J; Capizzi RL
    Cancer Treat Rep; 1987 Feb; 71(2):195-6. PubMed ID: 2948640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models.
    Trendowski M; Mitchell JM; Corsette CM; Acquafondata C; Fondy TP
    Invest New Drugs; 2015 Apr; 33(2):290-9. PubMed ID: 25563824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic activity of mitoxantrone and its biological interactions in parental and multidrug resistant subline of P388 murine leukemia cells.
    Chavan S; Parekh H; Chitnis M
    Neoplasma; 1992; 39(1):49-57. PubMed ID: 1528304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
    Hsu KH; Friedman H
    J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effectiveness of Cyclic Hydroxamic Acid CHA-5 against Drug-Resistant P388 Leukemia Strains.
    Goncharova SA; Vystorop IV; Raevskaya TA; Konovalova NP
    Bull Exp Biol Med; 2017 Jul; 163(3):385-388. PubMed ID: 28744633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
    Szmigielska-Kaplon A; Ciesielska E; Szmigiero L; Robak T
    Eur J Haematol; 2002 Jun; 68(6):370-5. PubMed ID: 12225395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-resistance of drug-resistant murine P388 leukemias to taxol in vivo.
    Waud WR; Gilbert KS; Harrison SD; Griswold DP
    Cancer Chemother Pharmacol; 1992; 31(3):255-7. PubMed ID: 1361163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of concomitant infusion of thymidine and inosine on methotrexate activity in normal and P388-bearing mice.
    Uitendaal MP; Schornagel JH; Leyva A; Pinedo HM
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1527-32. PubMed ID: 6542016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of the synergistic effect of oral dimethyl sulfoxide on antineoplastic therapy.
    Thuning CA; Fanshaw MS; Warren J
    Ann N Y Acad Sci; 1983; 411():150-60. PubMed ID: 6576691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
    Harrison SD; O'Dwyer PJ; Trader MW
    Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.